Active extracts of black tea (Camellia Sinensis) induce apoptosis of PC-3 prostate cancer cells via mitochondrial

Shili Sun1, Shunshun Pan, Aiqing Miao

  • 1Drink Plant Research Institute/Tea Research Center, Guangdong Academy of Agricultural Sciences, Guangzhou, Guangdong 510640, PR China.

Oncology Reports
|May 30, 2013
PubMed

Insights

Black tea extracts and theaflavins (TFs) inhibit prostate cancer cell growth. These compounds induce apoptosis and necrosis in PC-3 cells by disrupting mitochondrial function.

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • Prostate cancer is a leading cause of cancer death in men.
  • Black tea consumption is linked to reduced risk of various cancers.
  • Theaflavins (TFs) are key polyphenols found in black tea.

Purpose of the Study:

  • To investigate the anti-proliferative effects of black tea extracts and TFs on human prostate cancer cells (PC-3).
  • To explore the impact of these compounds on PC-3 cell morphology, apoptosis, necrosis, and mitochondrial function.

Main Methods:

  • Treatment of PC-3 cells with Yinghong black tea extracts (YBT), Assam black tea extracts (ABT), and TFs.
  • Assessment of cell proliferation, morphology, apoptosis, necrosis, mitochondrial membrane potential, cytochrome c release, ATP content, and caspase-3 activation.

Main Results:

  • YBT, ABT, and TFs demonstrated dose-dependent inhibition of PC-3 cell proliferation.
  • These agents altered PC-3 cell morphology and induced apoptosis and necrosis.
  • Significant disruption of mitochondrial function was observed, including loss of membrane potential, cytochrome c release, decreased ATP, and caspase-3 activation.

Conclusions:

  • Black tea extracts (YBT, ABT) and theaflavins (TFs) exhibit significant anti-proliferative activity against PC-3 prostate cancer cells.
  • The mechanism involves the induction of apoptosis and necrosis mediated by mitochondrial dysfunction.
  • Black tea compounds show potential as therapeutic agents for prostate cancer.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...